市场见解

These were the 5 worst performing ASX 200 shares in November

These ASX 200 shares were sold off in November…
The post These were the 5 worst performing ASX 200 shares in November appeared first on The Motley Fool Australia. –

November was a disappointing month for the S&P/ASX 200 Index (ASX: XJO). The benchmark index recorded its third consecutive monthly decline after dropping 0.9% over the period to 7,256 points.

While a good number of shares tumbled with the market, some fell more than most. Here’s why these were the worst performing ASX 200 shares last month:

Nearmap Ltd (ASX: NEA)

The Nearmap share price was the worst performer on the ASX 200 last month with a disappointing 27.6% decline. Investors were selling the aerial imagery technology and location data company’s shares despite it providing FY 2022 annual contract value (ACV) growth guidance of 17% to 24.8% year on year. Some investors may have been expecting stronger growth. In addition, the Utah Federal Court has denied Nearmap’s motion to dismiss two of Eagleview’s claims on the basis that the patents are invalid. This could have spooked investors.

Clinuvel Pharmaceuticals Limited (ASX: CUV)

The Clinuvel share price wasn’t far behind with a sizeable decline of 25.5% in November. This appears to have been driven by a broker note out of Jefferies. According to the note, the broker downgraded the biopharmaceutical company’s shares due partly to concerns over the launch of a new product competing with Clinuvel’s Scenesse therapy in the treatment of EPP.

Zip Co Ltd (ASX: Z1P)

The Zip share price was a poor performer and dropped 20.5% last month. This weakness could have been caused by reports in the United States which suggest that fraud is rising in the BNPL industry. An investigation apparently shows that criminals are exploiting weaknesses in the application process for BNPL loans and stealing items. This news offset a trading update which revealed that Zip’s strong growth continued during October. In fact, October was Zip’s highest TTV month on record, processing over $770 million in transaction volume for the month.

西太银行 (ASX: WBC)

The Westpac share price was sold off last month and sank 20.1% over the period. Investors were selling the banking giant’s shares following the release of its full year results. Although Westpac doubled its cash earnings in FY 2021, its net interest margin outlook weighed heavily on sentiment. It was largely because of this that Goldman Sachs downgraded the bank’s shares to a neutral rating with a $25.60 price target.

Polynovo Ltd (ASX: PNV)

The PolyNovo share price wasn’t far behind with a 19.8% decline in November. This medical device company’s shares were sold off following the surprise resignation of its Managing Director, Paul Brennan. According to the release, Mr Brennan’s interactions with senior staff and his management style led to increasing differences between him and the Board.

The post These were the 5 worst performing ASX 200 shares in November appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

More reading

These were the 5 best performing ASX 200 shares in November

2 ASX dividend shares that could provide rock-solid income

5 things to watch on the ASX 200 on Wednesday

Here are the top 10 ASX shares today

Here are the 3 heaviest traded ASX 200 shares on Tuesday so far

Motley Fool contributor James Mickleboro owns shares of Westpac Banking Corporation. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Nearmap Ltd., POLYNOVO FPO, and ZIPCOLTD FPO. The Motley Fool Australia owns shares of and has recommended Nearmap Ltd. The Motley Fool Australia has recommended Westpac Banking Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!